SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
IN8BIO INC
Common Stock, par value $0.0001 per share · CUSIP: 45674E109
Event date: 2025-05-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOS FUND II, LPReported CIK 0001714576
Shares: 574,432.00 · Class: 0.6%
- BIOS FUND II QP, LPReported CIK 0001716869
Shares: 1,876,624.00 · Class: 2.1%
- BIOS FUND II NT, LPReported CIK 0001728851
Shares: 251,211.00 · Class: 0.3%
- BIOS INCYSUS CO-INVEST I, LPReported CIK 0001740029
Shares: 997,433.00 · Class: 1.1%
- BIOS FUND III, LPReported CIK 0001791917
Shares: 570,724.00 · Class: 0.6%
- BIOS FUND III QP, LPReported CIK 0001791916
Shares: 3,727,597.00 · Class: 4.1%
- BIOS FUND III NT, LPReported CIK 0001791910
Shares: 601,980.00 · Class: 0.7%
- BIOS CLINICAL OPPORTUNITY FUND, LPReported CIK 0001988639
Shares: 3,140,803.00 · Class: 3.3%
- BP DIRECTORS, LPReported CIK 0001813311
Shares: 121,775.00 · Class: 0.1%
- BIOS EQUITY PARTNERS, LPReported CIK 0001813314
Shares: 121,775.00 · Class: 0.1%
- BIOS EQUITY PARTNERS II, LPReported CIK 0001813313
Shares: 3,699,700.00 · Class: 4.1%
- BIOS EQUITY PARTNERS III, LPReported CIK 0001831976
Shares: 4,900,301.00 · Class: 5.4%
- BIOS EQUITY COF, LPReported CIK 0002000747
Shares: 3,140,803.00 · Class: 3.3%
- CAVU MANAGEMENT, LPReported CIK 0001813270
Shares: 8,721,776.00 · Class: 9.6%
- BIOS CAPITAL MANAGEMENT, LPReported CIK 0001813845
Shares: 9,120,073.00 · Class: 9.99%
- CAVU ADVISORS, LLCReported CIK 0001813310
Shares: 8,721,776.00 · Class: 9.6%
- BIOS ADVISORS GP, LLCReported CIK 0001813844
Shares: 9,120,073.00 · Class: 9.9%
- LESLIE W. KREISReported CIK 0001813316
Shares: 8,721,776.00 · Class: 9.6%
- AARON G.L. FLETCHERReported CIK 0001789490
Shares: 9,120,073.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-046280
- Form type
- SCHEDULE 13D/A
- Filer
- BIOS Fund II, LP
- CIK
- CIK 1714576
- Filed
- May 08, 2025
- Reporting period
- May 02, 2025
- Description
- Schedule 13D beneficial ownership